ABSTRACT
The alginate (Alg) matrix with immobilized hydroxyapatite (HAp) and zinc oxide (ZnO), cross-linked by chitosan (CS) and metal ions (Men+) Ca2+, Zn2+, and Cu2+ was created as a wound dressing. The effect of Men+ and their concentrations on water vapor transition, fluid handling, dehydration, drug release, and healing are shown. Me-containing samples have a lower sorption capacity, than a commercial Kaltostat, however, a much lower degree of their dehydration provides a longer wound wet. The Men+ presence lowers the environmental pH to slightly acidic values promoting healing. Ca2+, Zn2+, and Cu2+ in complexes with CS increase antimicrobial effect against E. coli and S. aureus, slow down the Anaesthesine release, making it compatible with Fickian diffusion in the Zn2+ and Cu2+ presence, and non-Fickian transport under Ca2+ influence. The material promotes the proliferation of the fibroblasts, an increase of collagen fibres, and new arterial and venous capillaries, indicating the intensity of the healing process.
Subject(s)
Anti-Infective Agents , Chitosan , Humans , Alginates/pharmacology , Alginates/chemistry , Staphylococcus aureus , Escherichia coli , Dehydration , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Wound Healing , Anti-Infective Agents/pharmacology , Metals , Chitosan/pharmacology , Chitosan/chemistryABSTRACT
Composite based on nano-sized hydroxyapatite (HA), zinc oxide (ZnO), chitosan (CS), alginate (Alg) with the function of sustained Ceftriaxone (CF) release was created as molecular sorption-aspiration drainage system (SADS), designed for the treatment of purulent cavities of various genesis, including peritonitis. ZnO stabilizes the composite structurally, reducing the swelling by 1.5 and porosity by 1.4 times. The absorption of tryptophan (Trp) by SADS for 72 h from aqueous solution is 80%, while from PBS - 50%. The content of ZnO (15,20%) slows the CF release by 1.6 times on the first day of SADS installation and reduces the likelihood of "burst" drug release. CF release exponent of ZnO-containing composites indicates the non-Fickian diffusion kinetics. 20%ZnO-containing composite is closest to zero-order kinetics. The reduction of the concentration of E. coli microbial cells for 43% in the presence of HA-nZnO-Alg/CS -based CADS and positive therapeutic pathomorphosis were observed in vivo.